Media headlines about Cooper Companies (NYSE:COO) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cooper Companies earned a coverage optimism score of 0.11 on Accern’s scale. Accern also assigned headlines about the medical device company an impact score of 47.954284031352 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the headlines that may have effected Accern Sentiment’s rankings:
Cooper Companies stock opened at $231.84 on Thursday. The stock has a market capitalization of $11.52 billion, a PE ratio of 23.90, a PEG ratio of 1.85 and a beta of 0.61. The company has a current ratio of 2.76, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. Cooper Companies has a 12 month low of $216.47 and a 12 month high of $260.26.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, June 7th. The medical device company reported $2.86 EPS for the quarter, topping analysts’ consensus estimates of $2.84 by $0.02. The company had revenue of $631.30 million for the quarter, compared to the consensus estimate of $627.49 million. Cooper Companies had a return on equity of 17.14% and a net margin of 5.58%. The company’s quarterly revenue was up 20.8% compared to the same quarter last year. During the same period last year, the business posted $2.50 EPS. equities analysts forecast that Cooper Companies will post 11.81 earnings per share for the current fiscal year.
A number of analysts have issued reports on the company. TheStreet raised Cooper Companies from a “c+” rating to a “b-” rating in a research note on Friday, June 15th. ValuEngine raised Cooper Companies from a “sell” rating to a “hold” rating in a research note on Friday, June 15th. Oppenheimer set a $265.00 price target on Cooper Companies and gave the stock a “hold” rating in a research note on Friday, June 8th. Raymond James decreased their price target on Cooper Companies from $275.00 to $270.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 5th. Finally, Zacks Investment Research lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, May 28th. Ten investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $265.36.
In other news, Director Michael Kalkstein sold 1,715 shares of the firm’s stock in a transaction dated Wednesday, April 11th. The stock was sold at an average price of $221.66, for a total value of $380,146.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Allan E. Rubenstein sold 1,000 shares of the firm’s stock in a transaction dated Friday, June 15th. The stock was sold at an average price of $235.13, for a total value of $235,130.00. Following the completion of the transaction, the director now owns 4,568 shares in the company, valued at $1,074,073.84. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.